Ortho RTI received a clinical hold letter for Ortho-R, a regenerative product for rotator cuff repairs in June.
After addressing concerns, the company was cleared to proceed with clinical trials for Ortho-R. Ortho RTI plans to enroll 78 patients across 10 clinical sites for the trial.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.